Wednesday 15 January 2014

Update on Medication coverage policy - BCBS of california

blueshieldca - Medication Policy Update
Medication Coverage Policy Updates

Please note: As a result of the December 2010 Pharmacy and Therapeutics (P&T) Committee  meeting, Blue Shield of California is announcing updates to some medication coverage policies for office-based drugs covered in the medical benefit, as follows:
                          

New Office-Administered Medication Coverage Policies:
Iprivask
Xeomin


Updated Office-Administered Medication Coverage Policies:

Acthar H.P. Gel
Avastin
Avonex
Betaseron
Bexxar
Boniva
Botox
Clolar
Dacogen
Enbrel
Extavia
Forteo
Irinotecan
Novantrone
Octagam
Oxaliplatin
Prolia
Reclast
Rituxan
Torisel
Treanda
Tysabri
Vidaza
Vivitrol
Zevalin

For all changes and details, download the Fourth Quarter 2010 Formulary and Medication Coverage Policy Updates below (PDF, 62KB).

No comments:

Post a Comment

Popular Posts